S. 2513: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to transparency and reporting regarding over-the-counter drug monograph activities, and for other purposes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Jul. 29, 2025 | Introduced in Senate |
| Jul. 29, 2025 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.